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Abstract: A reliable method for non-invasive detection of dangerous intracranial pressure (ICP)
elevations is still unavailable. In this preliminary study, we investigate quantitatively our observation
that superimposing waveforms of transcranial Doppler blood flow velocity (FV) and arterial blood
pressure (ABP) may help in non-invasive identification of ICP plateau waves. Recordings of FV, ABP
and ICP in 160 patients with severe head injury (treated in the Neurocritical Care Unit at Adden-
brookes Hospital, Cambridge, UK) were reviewed retrospectively. From that cohort, we identified
18 plateau waves registered in eight patients. A “measure of dissimilarity” (Dissimilarity/Difference
Index, DI) between ABP and FV waveforms was calculated in three following steps: 1. fragmentation
of ABP and FV signal according to cardiac cycle; 2. obtaining the normalised representative ABP and
FV cycles; and finally; 3. assessing their difference, represented by the area between both curves. DI
appeared to discriminate ICP plateau waves from baseline episodes slightly better than conventional
pulsatility index did: area under ROC curve 0.92 vs. 0.90, sensitivity 0.81 vs. 0.69, accuracy 0.88 vs.
0.84, respectively. The concept of DI, if further tested and improved, might be used for non-invasive
detection of ICP plateau waves.
Keywords: intracranial pressure; transcranial Doppler; non-invasive plateau waves detection
1. Introduction
Given the multitude of biological events influencing intracranial pressure (ICP), it
should be perceived as “more than a number” [1]. Therefore, using only current ICP value,
without secondary analysis of signal and its time-dependent dynamics, contributes to
the therapy rather weakly [2,3]. In clinical practice, identifying patterns of ICP changes
over time, the best known of which are Lundberg’s “plateau waves” [4], has been proved
relevant [5–7]. Direct ICP measurement is considered essential in neurocritical care, but it
is not commonly used outside this environment due to limitations inherent to its invasive
nature. Considering this limitation of “traditional” ICP measurement, in our work, we
attempted to explore the potential of TCD in non-invasive detection of plateau waves. Our
method consists of superimposing the signal of transcranial Doppler sonography (TCD) on
the signal of arterial blood pressure (ABP) before and during plateau waves, and extracting
the difference in their shapes.
Plateau waves are observed in up to 25% of patients requiring neurocritical care [8]
and manifest as a rapid rise in ICP lasting from a few minutes to a few hours [9]. According
to the widely accepted theory presented by Rosner in 1982 [10], the plateau wave is a result
of vasodilatory cascade building up on physiological autoregulatory mechanisms in the
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face of drop in cerebral perfusion. The cost of this reaction is an increase in cerebral blood
volume which transfers directly to ICP, thus building a vicious circle. An occurrence of
a plateau wave is by no means a benign incident, even though most cases are clinically
occult and may cease spontaneously. In some unpredictable instances, the vasodilatory
reactions can break up out of “safe” limits to cause refractory brain ischemia and death. For
this reason, detection of these spontaneous ICP increases is of utmost clinical significance,
while non-invasive detection could be even more beneficial, especially for patients not
submitted to invasive ICP monitoring.
Blood flow velocity (FV) measured with transcranial Doppler (TCD) has been widely
accepted as a surrogate of cerebral blood flow (CBF), with the assumption that FV is pro-
portional to CBF if the unknown diameter of insonated vessel remains constant. Thanks to
its non-invasive nature and bedside availability, TCD-FV may be widely used in neuro-
critical care units, but as for ICP, FV also seems to carry more information than its mean
value. Many studies noted relevant information encoded in FV waveform changes, e.g.,
increased peak-systolic (FVs) and a drop in end-diastolic (FVd) flow velocity during pe-
riods of inadequate cerebral perfusion [11,12]. A ratio between those extreme points in
FV waveform, normalised to FV mean value, is known as Pulsatility Index (PI), and was
originally believed to be a descriptor of cerebrovascular resistance and a foundation for
non-invasive ICP estimation [13]. However, despite extensive work carried out to build a
non-invasive ICP estimator upon FV values, e.g., FVd, or FV-derived indices, such as PI,
there is still no reliable alternative to a direct ICP measurement [14,15], leaving a need for
further research into FV waveform analysis methods.
The aim of this work is to present a methodology for analysis of changes in shape of
TCD pulse waveform course in relation to that of ABP. Such a method, if robust, may serve
as an alternative of non-invasive plateau waves detection.
2. Materials and Methods
Retrospective analysis of previously published data was performed [5,16–20]. From
among 160 head-injured patients treated in the Neurocritical Care Unit, Addenbrooke’s
Hospital in the years 1992–1995, 31 presented ICP plateau waves, defined as a sudden rise
in ICP above the value of 40 mmHg that lasted at least 5 min. All of the patients were
analgosedated, intubated and mechanically ventilated to achieve mild hypocapnia (end-
tidal pCO2 3.5–4 kPa); further details on patients’ clinical data, treatment protocol and data
acquisition methodology were thoroughly described elsewhere [5]. In 96 patients, intermit-
tent recording of ICP, ABP and TCD was performed on a daily basis, for periods ranging
from 20 min to 4 h. A total of 18 recordings captured in 8 patients (2 women, 6 men; age
19–36 years) covered the entire course of plateau ICP wave and, therefore, were available
for analysis. Artefacts resulting from nursing interventions were removed manually.
Recordings were manually divided into periods of baseline ICP (normal or elevated)
and stable phases of plateau (Figure 1). An automatic detection of points characteristic to
each cardiac cycle, that is maximal (peak of systole) and minimal (end-diastolic) values [21],
was performed on courses of raw ABP and FV signals (Figure 2). Subsequently, signals
were sliced into single cardiac cycles, and then, the representative cycle of ABP as well as
that of FV were derived by a process of aligning all individual cycles and averaging them,
which reduced the noise. This technique also allowed us to reduce time delay between
ABP and FV signals.
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higher ability to detect plateau waves as opposed to PI; however, this difference is not 
significant. Amongst analysed indices, DIdif provides highest accuracy (0.875) and area 
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Representative cycles were normalised so as for ABP and FV to assume values between
0 and 1 (see Figure 3). Three variants of calculating dissimilarity between ABP and FV
waveforms, the latter referenced as Difference Index (DI), were proposed:
DIdif = 〈ABPt − FVt〉t = 〈ABP t〉t − 〈FV t〉t ,DIabs = 〈|ABPt − FVt|〉t ,DIrsq =
√
〈(ABPt − FVt)2〉t ,
where ABPt and FVt stand for normalised values of ABP and FV curves at time t, |·| sym-
bolises the absolute value, and 〈·〉t indicates averaging over time within the representative
cycle. While calculating DIdif depends on relation of the ABP and FV curves to each other,
that is which curve is above the other in given time point, DI based on absolute value
(DIabs) and root square (DIrsq) is proposed as independent from ABP to FV curve position
influence. Note that averaging the differences between ABP and FV curves over time, i.e.,
DIdif variant, is equivalent to subtracting the average values of ABP and FV curves.
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long segments. PI values were first obtained in 10 s-l ng segments and then av raged over
time to produce one representative value for each ba eline and plate u episode.
Normal distribution of the data was confirmed with Shapiro–Wilk test and, therefore,
a paired two-side t-test was used for further analysis. Values of DI before and during
an ICP plateau wave were compared. DI ability to differentiate between baseline and
plateau was compared against that of PI with receiver operating characteristic (ROC) curve
analysis.
Intracranial pressure was monitored with intraparenchymal sensors, either the Camino
Direct Pressure Monitor (Camino Laboratories, San Diego, CA, USA) or the Codman
Microsensors ICP Transducer (Codman and Shurtleff, Inc., Raynham, MA, USA).
Signal recording, editing, and pulse analysis were performed in ICM+ (https://
icmplus.neurosurg.cam.ac.uk; Cambridge Enterprise Ltd., Cambridge, UK; accessed on
13 May 2021). Following calculations and statistical analysis were conducted in Matlab
(MathWorks, Natick, MA, USA).
The data were collected during routine multimodal monitoring included in Protocol
30 REC 97/290, approved by a local bioethical committee. After anonymization, digital
recordings were retrospectively analysed as a part of clinical audit.
3. Results
A total of 18 recordings of plateau waves preceded by stable baseline period were
available for analysis. Mean values, standard deviation and results of paired t-test (base-
line vs. plateau) are presented in Table 1. During ICP plateau wave, values of DI were
significantly higher (p < 0.0001). Values of DI are different in three variants. According to
ROC analysis presented in Table 2 and Figure 4, DIdif yields somewhat higher ability to
detect plateau waves as opposed to PI; however, this difference is not significant. Amongst
analysed indices, DIdif provides highest accuracy (0.875) and area under a curve (0.918).
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Table 1. Basic characteristics of physiological parameters at baseline and during ICP plateau wave.
Baseline
(Mean ± Std. Dev.)
Plateau
(Mean ± Std. Dev.)
p Value
(Paired Two-Side t-Test)
ABP (mmHg) 95.1 ± 2.4 94.8 ± 2.3 0.9
ICP (mmHg) 24.9 ± 5.8 51.7 ± 2.3 0.0001
FV (cm/s) 61.1 ± 2.4 48.6 ± 2.2 0.006
FVs (cm/s) 116.0 ± 4.1 127.3 ± 5.3 0.0003
FVd (cm/s) 36.07 ± 2.3 21.25 ± 2.01 <10−4
PI 1.454 ± 0.094 2.446 ± 0.142 <10−4
DIdif 0.006 ± 0.031 0.054 ± 0.032 <10−4
DIabs 0.045 ± 0.021 0.082 ± 0.029 <10−4
DIrsq 0.061 ± 0.027 0.104 ± 0.037 <10−4
ABP—arterial blood pressure, ICP—intracranial pressure, FV—flow velocity, FVs—peak-systolic FV, FVd—end-
diastolic FV, PI—Gosling pulsatility index, DIdif, DIabs and DIrsq—three variants of the Difference Index as defined
in the Materials and Methods section.
Table 2. Receiver operating characteristic (ROC) curve showing the performance of given indices to
discriminate between baseline ICP vs. plateau wave. AUC—area under the curve, CI—confidence
interval.
DI_dif DI_abs DI_rsq PI
Sensitivity 0.813 0.813 0.813 0.688
Specificity 0.938 0.750 0.750 1
AUC 0.918 0.813 0.797 0.898
AUC 95% CI low 0.733 0.615 0.592 0.723
AUC 95% CI up 0.987 0.929 0.922 0.976
Accuracy 0.875 0.781 0.781 0.844Brain Sci. 2021, 11, x FOR PEER REVIEW 5 of 9  
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4. Discussion
In pursuit of a reliable, repeatable and user-independent non-invasive ICP estimator,
many modalities using various signal sources have been introduced, e.g., assessment of
ICP transmission through cochlear aqueduct or into the optic nerve sheath, measurement
of sound attenuation within the brain parenchyma, venous opthtalmodynamometry, and
others, including minimally invasive epidural sensors [23]. Among numerous techniques
available, TCD-waveform-based methods present some significant advantages, especially
a possibility of continuous monitoring that allows for identifying both long-term trends
and rapid changes of vascular origin.
Introduction of DI is an attempt to use simple, graphically-derived estimator to assess
exceptionally complex intracranial haemodynamics. The DI concept was based on the
observation that in physiological conditions, there is a striking resemblance between ABP
and FV waveforms. They might be roughly approximated to each other, since ABP is a
major driving force for CBF and, concordantly, FV. The more pathological intracranial
hemodynamics are, the more divergent ABP and FV waveform courses become.
Calculation of DI can be summarised in three steps: 1. fragmentation of ABP and FV
signal according to cardiac cycle; 2. obtaining the normalised representative ABP and FV
cycles by a process of aligning all individual cycles and averaging them; 3. applying the
formula to obtain the Difference Index, which might be described by the area between the
curves. In analysed clinical data, calculated difference between ABP and FV courses is
significantly higher (p < 0.0001) during plateau wave.
PI was chosen as reference to DI because during plateau wave, PI value also differed
significantly (p < 0.0001). Despite not being a good descriptor of ICP, in limited clinical
situations, that is normal CO2 pressure and arterial pressure, PI may serve as an indicator
of severe cerebral perfusion pressure (CPP) impairment.
DI, as a parameter derived from entire cardiac cycle waveform, provides a different
angle on phenomena previously analysed by PI as single points: increased peak-systolic
and diminished end-diastolic FV. Whereas PI is focused on the ratio between those extreme
values, DI underlines diminished flow during the entire diastolic phase of the cardiac
cycle. A drop in end-diastolic FV (FVd) value during the plateau wave was previously
linked with vasocollapse due to CPP below the threshold of critical closing pressure [17].
Diminished FVd, either alone or combined with PI, is a valuable indicator of ischemic
brain insult following traumatic brain injury [11,12,24]. The ratio FV/FVd can be utilised
in non-invasive ICP estimation [12,15].
Values of DIdif can be negative and are lower than those of DIabs and DIrsq (Table 1). This
is because for DIdif, a positive difference (ABPt > FVt) in one time point can be neutralised
by a negative difference (ABPt < FVt) in another point. On the other hand, DIabs and
DIrsq treat positive as well as negative differences in the same way regardless of their sign,
and simply accumulate them. DIrsq scores large differences between ABP and FV slightly
stronger than DIabs does. In practice, however, both indices produce very similar results
(R = 0.96). DIdif is also correlated with DIabs (R = 0.57) and DIrsq (R = 0.49).
According to ROC curves’ analysis, DIdif yields higher strength in plateau wave
detection than PI (AUC 0.918 vs. 0.898, respectively); however, this improvement is not
statistically significant in the study sample. Dissimilarities in calculation methodology of
DI and PI resulted in differences in sensitivity (0.813 vs. 0.688) and specificity (0.938 vs. 1,
respectively). In the clinical setting, remarkably higher sensitivity of DIdif to a potentially
harmful intracranial hypertension appears to be of value. Additionally, DIdif provides a
better trade-off between sensitivity and specificity, resulting in the highest probability of
detecting the real state of ICP (accuracy = 0.875).
In an example of ICP plateau waves, the most straightforward explanation of observed
ABP-FV waveform divergence would be a decrease in CPP caused by a sudden rise in
ICP. However, numerous other factors shaping CBF have been identified. Some of them,
such as heart rate and ABP pulse amplitude, can actually be measured; others might
be only estimated in models, e.g., cerebrovascular resistance or arterial bed compliance.
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An ICP plateau wave, as a product of a vasodilatatory vicious circle, refers to a series of
events affecting cerebral vasculature in many ways [25]. It is yet to be determined whether
difference in ABP-FV waveforms reflects diminished CPP, elevated ICP, low cerebrovascular
resistance, depleted cerebrospinal compliance or state of impaired cerebral autoregulation.
If further tested and interpreted in a context of aforementioned parameters, DI might
be found to be useful in the setting of invasive ICP measurement as an aid providing a
physiological background of observed changes.
Additionally, alterations in PaCO2 are known to change cerebrovascular resistance and,
therefore, can influence FV-based calculations. In our cohort, patients were mechanically
ventilated to achieve mild hypocapnia and alterations in PaCO2 were not recorded before
and after an onset of plateau wave. Therefore, despite that conclusions cannot be drawn
from presented material, we realise that an assessment of the relationship between CO2
and DI would provide valuable information about specificity of the presented index and
remains a goal for our further work.
ABP serves as an auto-reference for measurements of FV change, which is a “true”
variable. During plateau wave, changes in circulatory system have traditionally been
considered minor (in our data, there was no significant difference in mean ABP values,
p = 0.9). However, recent research indicates significance of sympathetic activity affecting
circulation, such as baroreflex and heart rate variability [26]. Using ABP curve as a reference
makes DI potentially resistant to changes affecting primarily the cardiac system.
Nevertheless, operations performed on ABP and FV waveforms may result in their
distortion. In order to refer FV to ABP—different physical quantities, i.e., velocity and
pressure, whose values are expressed in different units—a process of normalisation was
necessary. Minimal and maximal values in both curves were considered as reference points,
and hence, the normalisation was performed in such a way that they assumed values 0 and
1, respectively. However, peak-systolic and end-diastolic FV do change significantly during
a plateau wave when compared with baseline (p ≈ 10−4), and our reference points are
shifted as well, which makes calculation of DI potentially less robust. Elimination of that
problem could potentially strengthen DI. It is difficult, however, to propose an alternative
definition of reference point that would be valid for both ABP and TCD-FV waveforms.
Although analysed material was recorded in the 1990s, in our opinion the age of the
data is not a significant obstacle because, in a sense, the “old” data could provide better
insight into plateau waves’ physiology than those available today. A classic, CPP-oriented
treatment protocol that was used in fully sedated patients in those times consisted of only
limited intervention when ICP raised above 25 mmHg: mainly infusion of intravenous
mannitol solution. Thanks to digitalised, high-resolution TCD recordings, our retrospective
data might be interpreted as a “natural course” of ICP plateau waves not affected with
therapeutical interventions.
5. Limitations
Our results should be perceived as preliminary. Further technical improvement, vali-
dation in a whole-time series, in a larger cohort and in other clinical scenarios is necessary.
We used pressure measured in radial artery and zeroed at the level of the heart as a
surrogate of cerebral blood pressure. The application of transformation approximating
ascending aortic pressure could potentially influence DI.
DI is susceptible to limitations inherent to any TCD measurements, such as signal
transmission attenuation through the cranial vault. With currently available TCD method-
ology the lack of “acoustic window” in the temporal squama (which affects up to 8% of the
adult population) simply precludes the applicability of DI.
In order to detect plateau wave, a baseline recording is required. In the clinical setting,
without invasive ICP measurement, it is difficult to assess whether ICP is elevated or not.
Studies on healthy subjects would potentially provide reference values of DI.
Improvement of normalisation could strengthen power of DI in detecting plateau wave.
Brain Sci. 2021, 11, 1000 8 of 9
In this preliminary work, all 18 plateau waves identified in 8 patients were treated as
unrelated events. More rigorous statistical analysis in a larger cohort, however, could take
into account the issue of potential dependence among subjects’ multiple measurements by
employing, e.g., a mixed-effects model.
6. Conclusions
DI is a novel modality for FV analysis with potential for real-time, non-invasive
plateau wave detection. Further technical improvement and validation is necessary.
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